Work

Supplementary Table S4 from Preclinical Activity of PI3K Inhibitor Copanlisib in Gastrointestinal Stromal Tumor

Year: 2023

Type: supplementary-materials

Abstract: Drug combination effect of imatinib and copanlisib.

DOI: 10.1158/1535-7163.22520808

Authors: Alfonso García-Valverde, Jordi Rosell, Garazi Serna, Claudia Valverde, Joan Carles, Paolo Nuciforo, Jonathan A. Fletcher, Joaquín Arribas, Oliver Politz, César Serrano

Language: English

Topic: Gastrointestinal Tumor Research and Treatment

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362490203

Cites:

Cited by:

Related to: 10